期刊文献+

腹腔镜下卵巢打孔术联合二甲双胍治疗多囊卵巢综合征的临床分析 被引量:7

Clinical analysis of laparoscopic ovarian drilling combined with metformin in treatment of polycystic ovary syndrome
下载PDF
导出
摘要 目的探讨腹腔镜下卵巢打孔术联合二甲双胍对多囊卵巢综合征(PCOS)的疗效价值。方法将2011年1月至2014年1月本院收治的80例PCOS患者按随机数字表法分为观察组和对照组,每组40例。观察组采用腹腔镜下卵巢打孔术(LOD)联合二甲双胍治疗,对照组采用氯米芬联合二甲双胍治疗。观察两组患者治疗前后黄体生成素(LH)、卵泡刺激素(FSH)、睾酮(T)及雌二醇(E2)水平,并随访患者的月经周期、排卵和妊娠情况。结果观察组治疗后的LH、FSH、T及E2改善情况均优于对照组,差异有统计学意义(P<0.05)。在月经周期、排卵及妊娠方面比较,观察组也显著优于对照组(P<0.05)。结论腹腔镜下卵巢打孔术联合二甲双胍治疗多囊卵巢综合征疗效的满意,并能改善患者的生活质量,提高妊娠率。 Objective To observe the clinical effect of laparoscopic ovarian drilling combined with metformin in treatment of poly- cystic ovary syndrome(PCOS). Methods Totally 80 patients with PCOS received in our hospital between January 2011 and Janu- ary 2014 were randomly divided into two groups. The observation group consisted of 40 patients were treated by ]aparoscopic ovarian drilling combined with mefformin, while the control group received elomiphene citrate combined with mefformin. The serum concen- tration of ]uteinizing hormone ( LH ), follicle-stimulating hormone ( FSH ), testosterone (T) and estradiol ( E2 ) were respectively com- pared before and after treatment. Menstruation cycle, ovulation rate and pregnancy rate were investigated and compared. Results Improvement of LH, FSH, T and E2 in observation group was significantly superior than in control group( P 〈 0.05 ). The menstrua- tion recover, ovulation rate and pregnancy rate of observation group was also significantly better than that of control group ( P 〈 0. 05 ). Conclusion Laparoscopic ovarian drilling combined with mefformin is reliable and effective treatment of PCOS. It can in- crease pregnancy rate and improve living quality of patients.
出处 《临床军医杂志》 CAS 2015年第7期677-679,共3页 Clinical Journal of Medical Officers
关键词 多囊卵巢综合征 腹腔镜下卵巢打孔术 二甲双胍 Polycystic ovarian syndrome(PCOS) Laparoscopic ovarian drilling(LOD) Metformin
  • 相关文献

参考文献13

  • 1谢幸.妇产科学[M].北京:人民卫生出版社,2013:274.
  • 2Palomba S,Falbo A,Zullo F.Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance[J].Curr Opin Obstet Gynecol,2009,21(6):465-73.
  • 3Gjonnaess H.Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoseope[J].Fertil Steril,1984,41(1):20-25.
  • 4Flyckt R L,Goldberg J M.Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome[J].Semin Reprod Med,2011,29(2):138-146.
  • 5Fernandez H,Morin-Surruca M,Torre A,et al.Ovarian drilling for surgical treatment of polycystic ovarian syndrome[J].Reprod Biomed Online,2011,22(6):556-558.
  • 6崔琳琳,陈子江.多囊卵巢综合征诊断标准和诊疗指南介绍[J].国际生殖健康/计划生育杂志,2011,30(5):405-408. 被引量:293
  • 7李小英.重视多囊卵巢综合征患者的代谢异常[J].中华内分泌代谢杂志,2010,26(5):349-350. 被引量:12
  • 8Yildiz B,Bozdag G,Yapici Z,et a1.Prevalence,phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria[J].Hum Reprod,2012,27(10):3067-3073.
  • 9蒋建发,孙爱军.多囊卵巢综合征手术治疗的利与弊[J].中国实用妇科与产科杂志,2013,29(11):856-860. 被引量:12
  • 10Seow K M,Juan CC,Hwang JL,et al.Laparoscopic surgery in polycystic ovary syndrome:reproductive and metabolic effects[J].Semin Reprod Med,2008,26(1):101-110.

二级参考文献83

  • 1吴效科,苏延华.多囊卵巢综合征病理生理学进展[J].生殖医学杂志,1995,4(2):119-123. 被引量:9
  • 2Stein IF,Leventhal ML.Amenonhea associated with bilateral polycystic ovaries.Am J Obstet Gynecol,1935,29:181-191.
  • 3Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod,2004,19:41-47.
  • 4Ehrmann D,Liljenquist D,Kasza K,et al.Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.J Clin Endocrinol Metab.2006,91:48-53.
  • 5Azziz R,Ehrmann D,Legro RS,et al.Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome:a multicenter,double blind,placebo-controlled trial.J Clin Endocrinol Metab,2001,86:1626-1632.
  • 6Ehrmann DA,Barnes RB,Rosenfield RL,et al.Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care,1999,22:141-146.
  • 7Zhang YF,Yang YS,Hong J,et al.Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.Endocrine,2006,29:419-423.
  • 8Solomon CG,Hu FB,Dunaif A,et al.Menstrual cycle irregularity and risk for future cardiovascular disease.J Clin Endocrinol Metab,2002,87:2013-2017.
  • 9Zawadski A,Dunaif A.Diagnostic criteria for polycystic ovary syndrome; towards a rational approach[M] /Dunatf A,Givens JR,Haseltine F.Polycystic Ovary Syndrome.Boston Blackwell Scientic,1992:377-384.
  • 10Rotterdam ESHRE/ASRM-Sponsored PCOS consensus worlcshop group.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19(1):41-d7.

共引文献718

同被引文献84

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部